Protein A Resin For Antibody Fragment Purification

New biological modalities, such as antibody fragments, are rapidly emerging as candidate therapeutics for challenging disease targets. Non-classical antibody constructs come with downstream challenges, as modifications are necessary to develop an effective and robust process on an accelerated timeline. This technical poster will discuss how an alkali stable protein A resin can be used as a platform resin for fragment mAb purification.